Enzyme activities and deoxynucleoside utilization of leukemic leukocytes in relation to drug therapy and resistance.
D002908:Chronic Disease; D003520:Cyclophosphamide / Q000627:therapeutic use; D004247:DNA / Q000096:biosynthesis; D003857:Deoxyuridine / Q000378:metabolism; D006801:Humans; D007938:Leukemia / Q000188:drug therapy* / Q000201:enzymology / Q000378:metabolism / Q000473:pathology; D007945:Leukemia, Lymphoid / Q000378:metabolism; D007951:Leukemia, Myeloid / Q000378:metabolism; D015470:Leukemia, Myeloid, Acute / Q000378:metabolism; D007958:Leukocyte Count; D007962:Leukocytes / Q000201:enzymology* / Q000378:metabolism; D008025:Ligases / Q000378:metabolism*; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D009705:Nucleosides / Q000378:metabolism*; D009711:Nucleotides / Q000378:metabolism; D010770:Phosphotransferases / Q000378:metabolism*; D013762:Tetrahydrofolate Dehydrogenase / Q000378:metabolism*; D013937:Thymidine Kinase / Q000378:metabolism*
D009705:Nucleosides; D009711:Nucleotides; D003520:Cyclophosphamide; D004247:DNA; D015122:Mercaptopurine; D013762:Tetrahydrofolate Dehydrogenase; D010770:Phosphotransferases; D013937:Thymidine Kinase; D008025:Ligases; D003857:Deoxyuridine; D008727:Methotrexate